| 1 |
Rational drug design to explore the structure-activity relationship (SAR) of TRK inhibitors with 2,4-diaminopyrimidine scaffold |
|
|
| Tianxiao Wu, Qiaohua Qin, Nian Liu, Chu Zhang, Ruicheng Lv, Wenbo Yin, Yin Sun, Yixiang Sun, Ruifeng Wang, Dongmei Zhao, Maosheng Cheng |
|
| European Journal of Medicinal Chemistry. 2022; : 114096 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Appraisal of cytohistomorphology of papillary carcinoma thyroid and its variants with evaluation of discrepant cases |
|
|
| Supreetha Megalamane, Hemalatha Anatharamiah, CS B. R. Prasad |
|
| Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2022; 0(0): 0 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Cytohistological Concordance of Papillary Carcinoma of Thyroid and Its Variants |
|
|
| Nameera Saleem, Naval Kishore Bajaj, Ezhil Arasi Nagamuthu |
|
| Journal of Evidence Based Medicine and Healthcare. 2021; 8(04): 213 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application |
|
|
| Wei Yan,Naga Rajiv Lakkaniga,Francesca Carlomagno,Massimo Santoro,Neil Q. McDonald,Fengping Lv,Naresh Gunaganti,Brendan Frett,Hong-yu Li |
|
| Journal of Medicinal Chemistry. 2019; 62(4): 1731 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma |
|
|
| Fangzhou Liu,Rong Yin,Xinyuan Chen,Wei Chen,Yichun Qian,Yanbin Zhao,Yuan Jiang,Dawei Ma,Tingting Hu,Tonghua Yu,Yan Zhu,Yuan Zhang |
|
| Biomedicine & Pharmacotherapy. 2019; 114: 108605 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Artificial Intelligence in Cytopathology: A Neural Network to Identify Papillary Carcinoma on Thyroid Fine-Needle Aspiration Cytology Smears |
|
|
| Parikshit Sanyal, Tanushri Mukherjee, Sanghita Barui, Avinash Das, Prabaha Gangopadhyay |
|
| Journal of Pathology Informatics. 2018; 9(1): 43 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
CYTOKERATIN 19 IMMUNOREACTIVITY IN PAPILLARY THYROID CARCINOMA |
|
|
| Chithira Balakrishnan,Sheela Varghese,Sankar S |
|
| Journal of Evolution of Medical and Dental Sciences. 2017; 6(77): 5474 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
p63 inhibits CD44+/CD24- cell proliferation and chemoresistance in papillary thyroid carcinoma cells |
|
|
| Jing-Jing Guo, Hong-Shun Xu, Gang Wu, Zhen-Yu Ma |
|
| Experimental and Therapeutic Medicine. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
